PH13537A - 16-methyl-9-halo steroid esters and preparation thereof - Google Patents
16-methyl-9-halo steroid esters and preparation thereofInfo
- Publication number
- PH13537A PH13537A PH16967A PH16967A PH13537A PH 13537 A PH13537 A PH 13537A PH 16967 A PH16967 A PH 16967A PH 16967 A PH16967 A PH 16967A PH 13537 A PH13537 A PH 13537A
- Authority
- PH
- Philippines
- Prior art keywords
- methyl
- preparation
- steroid esters
- halo steroid
- halo
- Prior art date
Links
- -1 -halo steroid esters Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
- C07J7/0055—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PT6163674 | 1974-03-27 | ||
PT6163774 | 1974-03-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
PH13537A true PH13537A (en) | 1980-06-19 |
Family
ID=26653426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH16967A PH13537A (en) | 1974-03-27 | 1975-03-25 | 16-methyl-9-halo steroid esters and preparation thereof |
Country Status (9)
Country | Link |
---|---|
US (1) | US4024131A (nl) |
JP (2) | JPS6043358B2 (nl) |
AU (1) | AU500060B2 (nl) |
CA (1) | CA1065848A (nl) |
DE (1) | DE2512915A1 (nl) |
HK (2) | HK64779A (nl) |
NL (1) | NL184321C (nl) |
PH (1) | PH13537A (nl) |
SE (1) | SE418294B (nl) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4201778A (en) * | 1977-11-08 | 1980-05-06 | Schering Corporation | 6-Acyloxy-1,4,6-pregnatrienes, their use as anti-inflammatory agents, methods for their manufacture, and 6-oxo-1,4-pregnadiene intermediates |
DE3068965D1 (en) * | 1979-11-16 | 1984-09-20 | Sterosynt Ltd | 6-alpha-fluoro-16-methyl-prednisolone-17,21 diesters and pharmaceutical compositions containing them |
PT71309A (en) * | 1980-05-27 | 1980-06-01 | Hovione Sociedade Quimica Lda | Process of selective |
IL66432A0 (en) * | 1981-08-04 | 1982-12-31 | Plurichemie Anstalt | Process for the preparation of steroidal esters |
PT78973A (en) * | 1984-07-25 | 1984-08-01 | Joao Emerico Villax | New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid |
JPS62111184U (nl) * | 1985-12-29 | 1987-07-15 | ||
JPH07116215B2 (ja) * | 1989-04-19 | 1995-12-13 | エスエス製薬株式会社 | 新規なステロイド化合物 |
DK1344526T3 (da) * | 2000-12-22 | 2008-09-15 | Nippon Shinyaku Co Ltd | Midler til forebyggelse/behandling af inflammatoriske luftvejslidelser |
CN104558083B (zh) * | 2013-10-16 | 2018-08-31 | 天津金耀集团有限公司 | 一种倍氯米松双丙酸酯无有机溶剂的合成方法 |
CN104558082B (zh) * | 2013-10-16 | 2018-01-23 | 天津金耀集团有限公司 | 一种倍氯米松双丙酸酯的合成方法 |
CN111944002A (zh) * | 2020-07-29 | 2020-11-17 | 河南利华制药有限公司 | 一种倍氯米松二丙酸酯中间体及制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1047518A (en) * | 1963-06-11 | 1966-11-02 | Glaxo Lab Ltd | 17ª-monoesters of 11,17,21-trihydroxy steroid compounds |
GB1070751A (en) * | 1964-01-28 | 1967-06-01 | Glaxo Lab Ltd | 17-esters of 17-hydroxy-21-desoxy-steroids |
NL6612191A (nl) * | 1965-08-30 | 1967-03-01 | ||
US3639434A (en) * | 1967-02-02 | 1972-02-01 | Boots Pure Drug Co Ltd | 17-acyloxysteroids and their manufacture |
CH534144A (de) * | 1967-11-17 | 1973-02-28 | Ciba Geigy Ag | Verfahren zur Herstellung neuer Halogenpregnadiene |
GB1227992A (nl) * | 1968-01-23 | 1971-04-15 | Koninklijke Gist Spiritus | |
GB1281689A (en) * | 1968-10-14 | 1972-07-12 | Glaxo Lab Ltd | Steroid 21-phosphates |
BE785812A (fr) * | 1971-07-05 | 1973-01-04 | Glaxo Lab Ltd | Nouveaux composes steroides |
-
1975
- 1975-03-24 DE DE19752512915 patent/DE2512915A1/de active Granted
- 1975-03-24 SE SE7503356A patent/SE418294B/xx not_active IP Right Cessation
- 1975-03-25 US US05/561,948 patent/US4024131A/en not_active Expired - Lifetime
- 1975-03-25 PH PH16967A patent/PH13537A/en unknown
- 1975-03-26 CA CA223,091A patent/CA1065848A/en not_active Expired
- 1975-03-26 JP JP50036524A patent/JPS6043358B2/ja not_active Expired
- 1975-03-27 AU AU79603/75A patent/AU500060B2/en not_active Expired
- 1975-03-27 NL NLAANVRAGE7503788,A patent/NL184321C/nl not_active IP Right Cessation
-
1979
- 1979-09-13 HK HK647/79A patent/HK64779A/xx unknown
- 1979-09-13 HK HK646/79A patent/HK64679A/xx unknown
-
1983
- 1983-04-21 JP JP58069325A patent/JPS58189200A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS6241680B2 (nl) | 1987-09-03 |
CA1065848A (en) | 1979-11-06 |
NL184321C (nl) | 1989-06-16 |
JPS50157353A (nl) | 1975-12-19 |
HK64779A (en) | 1979-09-21 |
AU7960375A (en) | 1976-09-30 |
SE418294B (sv) | 1981-05-18 |
DE2512915A1 (de) | 1975-10-09 |
US4024131A (en) | 1977-05-17 |
SE7503356L (nl) | 1975-09-29 |
NL184321B (nl) | 1989-01-16 |
JPS6043358B2 (ja) | 1985-09-27 |
JPS58189200A (ja) | 1983-11-04 |
DE2512915C2 (nl) | 1987-09-10 |
NL7503788A (nl) | 1975-09-30 |
HK64679A (en) | 1979-09-21 |
AU500060B2 (en) | 1979-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA755929B (en) | Aminobenzazocines and preparation thereof | |
ZA754975B (en) | 7-methoxy-6-thiatetracyclines and their preparation | |
PH13537A (en) | 16-methyl-9-halo steroid esters and preparation thereof | |
GB1520149A (en) | 4-methylthio-2-trifluoromethylmethanesulphonanilide and deivatives thereof | |
IL49103A0 (en) | Terpenoid esters of steroids | |
ZA75221B (en) | Phosphors and their preparation | |
PH13826A (en) | 8-halo-dibenzofuras-3-acetic acids and certain esters thereof | |
AU473007B2 (en) | Tirazoloquinazolines and preparation thereof | |
GB1516668A (en) | N2-naphthalenesulphonyl-l-arginine esters and amides | |
IL48665A0 (en) | 3-fluorobenzodiazepines and processes for their preparation | |
JPS5265260A (en) | Steroids and preparation thereof* | |
PH12178A (en) | 11-substituted steroids of the estrane series and pharmaceutical composition thereof | |
GB1520444A (en) | Preparation of unsaturated ethers and esters | |
ZA751599B (en) | 16-methyl-9alpha-halo steroid esters, ethers and preparation thereof | |
IL46635A0 (en) | New cephalosporin esters and their preparation | |
ZA757881B (en) | 3-fluorobenzodiazepines and processes for their preparation | |
GB1517153A (en) | Naphthopyran-and benzodipyran-2-carboxylic acids and derivatives thereof | |
GB1524242A (en) | D-homosteroid 21-oic acids and derivatives thereof | |
GB1488068A (en) | 7alpha-alkoxy-cephalosporin derivatives and their preparation | |
JPS5259149A (en) | Steroids and preparation thereof | |
GB1517946A (en) | Carbonic acid esters and the preparation thereof | |
GB1483948A (en) | Aliphatic and cycloaliphatic beta-keto esters | |
ZA752349B (en) | New nitroimidazolyl-triazolo-pyridazines and the preparation thereof | |
GB1486847A (en) | Carboxy-cyproheptadines their preparation and use | |
PH12296A (en) | D-homo-pregnene steroids |